Releuko (filgrastim-ayow)
Oncology Supportive Care
ApprovedCommercial
Key Facts
About Amneal Pharmaceuticals
Amneal Pharmaceuticals is a publicly traded, integrated biopharmaceutical company with a 20+ year history focused on expanding access to essential medicines. It operates across three core segments: Complex Generics, Biosciences (biosimilars and injectables), and Specialty branded pharmaceuticals, primarily in CNS and endocrine disorders. The company leverages over 1 million square feet of U.S. manufacturing capacity, has a robust pipeline with 69 pending ANDAs, and is led by its founding Patel brothers, aiming to bring manufacturing of critical medicines back to the United States.
View full company profileTherapeutic Areas
Other Oncology Supportive Care Drugs
| Drug | Company | Phase |
|---|---|---|
| Fylnetra (pegfilgrastim-pbbk) | Amneal Pharmaceuticals | Approved |
| Boruzu | Amneal Pharmaceuticals | Approved |